These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11522010)
1. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor. Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010 [TBL] [Abstract][Full Text] [Related]
2. Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex. Bhiladvala P; Strandberg K; Stenflo J; Holm J Thromb Res; 2006; 118(2):213-9. PubMed ID: 16098566 [TBL] [Abstract][Full Text] [Related]
3. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients. Bakoush O; Ohlin AK; Strandberg K; Kurkus J Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177 [TBL] [Abstract][Full Text] [Related]
4. The complex between activated protein C and protein C inhibitor: A clinically useful indicator of aortic aneurysms? Stenflo J; Kjellberg M; Strandberg K; Svensson PJ; Kölbel T; Lindblad B Blood Cells Mol Dis; 2006; 36(2):118-21. PubMed ID: 16466952 [TBL] [Abstract][Full Text] [Related]
5. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma. España F; Estelles A; Griffin JH; Aznar J Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876 [TBL] [Abstract][Full Text] [Related]
6. Protein C and its inhibitor in malignancy. Suzuki K; Hayashi T Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793 [TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity. Strandberg K; Svensson PJ; Ohlin AK Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343 [TBL] [Abstract][Full Text] [Related]
8. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma. Marlar RA; Kressin DC; Madden RM Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358 [TBL] [Abstract][Full Text] [Related]
10. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels. Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor. Suzuki K FEBS J; 2010 May; 277(10):2223-9. PubMed ID: 20402764 [TBL] [Abstract][Full Text] [Related]
12. A novel ELISA for mouse activated protein C in plasma. Fernández JA; Lentz SR; Dwyre DM; Griffin JH J Immunol Methods; 2006 Jul; 314(1-2):174-81. PubMed ID: 16828789 [TBL] [Abstract][Full Text] [Related]
13. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms. Kölbel T; Strandberg K; Mattiasson I; Stenflo J; Lindblad B J Vasc Surg; 2006 May; 43(5):935-9. PubMed ID: 16678686 [TBL] [Abstract][Full Text] [Related]
14. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor. Shen L; Villoutreix BO; Dahlbäck B Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457 [TBL] [Abstract][Full Text] [Related]
15. Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis. Strandberg K; Astermark J; Björgell O; Becker C; Nilsson PE; Stenflo J Thromb Haemost; 2001 Dec; 86(6):1400-8. PubMed ID: 11776306 [TBL] [Abstract][Full Text] [Related]
16. [Molecular marker for anticoagulant protein C pathway (APC-PCI complex)]. Hamada T; Kamada H; Suzuki K Nihon Rinsho; 2004 Dec; 62 Suppl 12():674-7. PubMed ID: 15658421 [No Abstract] [Full Text] [Related]
17. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard. España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042 [TBL] [Abstract][Full Text] [Related]
18. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin. van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521 [TBL] [Abstract][Full Text] [Related]
19. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma. Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217 [TBL] [Abstract][Full Text] [Related]
20. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo. Orthner CL; Kolen B; Drohan WN Thromb Haemost; 1993 May; 69(5):441-7. PubMed ID: 8322267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]